Swedish Cancer Institute; STE 1020 is a clinical research site located in Seattle, Washington, United States 98104.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Swedish Cancer Institute; STE 1020 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.
Sponsors: Loxo Oncology, Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Swedish Cancer Institute; STE 1020 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Swedish Cancer Institute; STE 1020 has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.
Swedish Cancer Institute; STE 1020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.